Table 2.

Literature review for COVID-19 infection and LVAD support

Case report Author	Age Gender of patient	Clinical course	Antiviral medication	Oxygen need	ECMO necessity during hospital admission	Confirmed COVID-19 infection with PCR analysis	Clinical result
Rassaf et al.	30 Male	Patient was admitted with diagnosis of ıdiopathic cardiomyopathy. LVAD was implanted successfully while patient was actively infected with COVID-19	NA	Intubated	Yes	Yes	Discharge
Korada et al	48 Female	She referred to the hospital with respiratory symptoms. Primary evaluation resulted in negative for COVID-19. After discharge and re-admission with same symptoms she was treated for 45-days in hospital for COVID-19	Lopinavir–ritonavir	Nasal oxygen No intubation	No	1. No 2. Yes	Discharge
Singh et al	66 Male	Has ARDS and septic shock. At the time of writing, the patient remains critically ill; however, there has been clinical improvement	First hydroxyqloroqine and oseltamivir Then lopinavir–ritonavir	Intubated	No	Yes	Still in hospital
Frick et al	56 Female	Has a history of pump thrombosis two times. Patient had pump thrombosis at the time of COVID infection again. Treated with heparin	NA	NA	No	Yes	Discharge
Chan et al	70 Male	Had ARDS and MODS	Hydroxyqloroqine then tocilizumab	Intubated	No	Yes	Lost
Kiran et al	54 Male	Previously LVAD implanted patient. The patient has a history of HIV/AIDS infection and Kaposi Sarcoma (treated with radiation.) Had mild COVID-19 symptoms	Hydroxyqloroqine	No need for oxygen	No	Yes	Discharge